Impaired glucose tolerance in obese
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
New Onset Diabetes After Transplant
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
6
|
1
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Type 2 diabetes mellitus in obese
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
7
|
4
|
0.010 |
None |
1.000 |
1 |
1
|
2008 |
2008 |
Ankle brachial pressure index (observable entity)
|
phenotype |
|
Clinical Attribute
|
7
|
40
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Chronic nasopharyngitis
|
disease |
Infections; Respiratory Tract Diseases; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
12
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Ileal Diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
14
|
7
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Insulin measurement
|
phenotype |
|
Laboratory Procedure
|
15
|
25
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Glucose tolerance test
|
phenotype |
|
Laboratory Procedure
|
17
|
28
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Premature adrenarche
|
disease |
|
Disease or Syndrome
|
18
|
11
|
0.010 |
None |
< 0.001 |
1 |
2
|
2009 |
2009 |
Left Ventricle Remodeling
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organ or Tissue Function
|
21
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Ventricular Remodeling
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organ or Tissue Function
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
TROPICAL CALCIFIC PANCREATITIS
|
disease |
Digestive System Diseases; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
24
|
13
|
0.010 |
None |
1.000 |
1 |
2
|
2008 |
2008 |
Autoantibody measurement
|
phenotype |
|
Laboratory Procedure
|
27
|
52
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Decreased waist to hip ratio
|
phenotype |
|
Finding
|
28
|
|
0.100 |
None |
|
0 |
|
|
|
metabolic disturbance
|
disease |
|
Disease or Syndrome
|
29
|
4
|
0.020 |
None |
1.000 |
2 |
1
|
2015 |
2018 |
Autonomic neuropathy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
29
|
7
|
0.010 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Hereditary Multiple Exostoses
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Musculoskeletal Diseases
|
Congenital Abnormality
|
32
|
51
|
0.010 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Adenocarcinoma of the gastroesophageal junction
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
32
|
6
|
0.010 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
cervical cancer metastasis
|
disease |
|
Neoplastic Process
|
35
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Atherogenic dyslipidaemia
|
disease |
|
Disease or Syndrome
|
36
|
9
|
0.010 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Exostoses
|
phenotype |
Musculoskeletal Diseases
|
Disease or Syndrome
|
37
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Latent Autoimmune Diabetes in Adults
|
disease |
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
39
|
12
|
0.040 |
None |
1.000 |
4 |
1
|
2010 |
2019 |
Fetal Alcohol Spectrum Disorders
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Chemically-Induced Disorders
|
Disease or Syndrome; Congenital Abnormality
|
46
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Latent autoimmune diabetes mellitus in adult
|
disease |
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
49
|
12
|
0.080 |
None |
1.000 |
8 |
1
|
2008 |
2019 |
Glycosuria
|
phenotype |
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Finding
|
53
|
7
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |